Product Information
PYRIDOSTIGMINE BR 30 MG TABLET is a generic product labeled by Method Pharmaceuticals LLC, priced at $6.9550 per EA under NDC 58657081021. Its NADAC has been published 102 times since Jul 17, 2024.
The High Outlier badge above means this manufacturer's average price in the PYRIDOSTIGMINE BROMIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657081021
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211181On Market Since
6/1/2019
Pharmacological Classes
Price Statistics
The NADAC for PYRIDOSTIGMINE BR 30 MG TABLET has been published 102 times since Jul 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9550 per EA |
|---|---|
| All-time high | $6.9619 (Sep 10, 2025) |
| All-time low | $6.8710 (Jul 17, 2024) |
| 52-week high | $6.9619 |
| 52-week low | $6.9300 |
| Median price | $6.9410 |
| Average price | $6.9400 |
| Largest weekly change | +0.6% (Aug 21, 2024) |
| Weeks tracked | 102 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PYRIDOSTIGMINE BROMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PYRIDOSTIGMINE BR 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PYRIDOSTIGMINE BR 30 MG TABLET, manufactured by Method Pharmaceuticals LLC, is $6.9550 per EA (NDC 58657081021), effective Jun 24, 2026.
How has the price of PYRIDOSTIGMINE BR 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PYRIDOSTIGMINE BR 30 MG TABLET has held within roughly two percent of its current level. It has been tracked across 102 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for PYRIDOSTIGMINE BR 30 MG TABLET?
Since Jul 17, 2024, the NADAC for PYRIDOSTIGMINE BR 30 MG TABLET has ranged from a low of $6.8710 (Jul 17, 2024) to a high of $6.9619 (Sep 10, 2025), with a median of $6.9410 per EA.
Are there cheaper alternatives to PYRIDOSTIGMINE BR 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PYRIDOSTIGMINE BR 30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PYRIDOSTIGMINE BR 30 MG TABLET?
PYRIDOSTIGMINE BR 30 MG TABLET (NDC 58657081021) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification